Logo image of DSGX

DESCARTES SYSTEMS GRP/THE (DSGX) Stock Fundamental Analysis

NASDAQ:DSGX - Nasdaq - CA2499061083 - Common Stock - Currency: USD

114.05  -4.64 (-3.91%)

After market: 114.05 0 (0%)

Fundamental Rating

7

Taking everything into account, DSGX scores 7 out of 10 in our fundamental rating. DSGX was compared to 283 industry peers in the Software industry. DSGX gets an excellent profitability rating and is at the same time showing great financial health properties. DSGX is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings would make DSGX suitable for growth and quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year DSGX was profitable.
In the past year DSGX had a positive cash flow from operations.
DSGX had positive earnings in 4 of the past 5 years.
Of the past 5 years DSGX 4 years had a positive operating cash flow.
DSGX Yearly Net Income VS EBIT VS OCF VS FCFDSGX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

1.2 Ratios

DSGX's Return On Assets of 8.51% is amongst the best of the industry. DSGX outperforms 84.06% of its industry peers.
DSGX's Return On Equity of 10.16% is fine compared to the rest of the industry. DSGX outperforms 79.35% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.11%, DSGX belongs to the top of the industry, outperforming 84.78% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for DSGX is below the industry average of 11.99%.
The 3 year average ROIC (8.30%) for DSGX is below the current ROIC(9.11%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.51%
ROE 10.16%
ROIC 9.11%
ROA(3y)7.64%
ROA(5y)6.35%
ROE(3y)9.1%
ROE(5y)7.5%
ROIC(3y)8.3%
ROIC(5y)7.07%
DSGX Yearly ROA, ROE, ROICDSGX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8

1.3 Margins

DSGX's Profit Margin of 21.80% is amongst the best of the industry. DSGX outperforms 88.77% of its industry peers.
DSGX's Profit Margin has improved in the last couple of years.
DSGX has a better Operating Margin (26.37%) than 93.12% of its industry peers.
In the last couple of years the Operating Margin of DSGX has grown nicely.
DSGX's Gross Margin of 75.43% is fine compared to the rest of the industry. DSGX outperforms 68.12% of its industry peers.
DSGX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 26.37%
PM (TTM) 21.8%
GM 75.43%
OM growth 3Y6.52%
OM growth 5Y8.82%
PM growth 3Y10.63%
PM growth 5Y12.21%
GM growth 3Y0.73%
GM growth 5Y0.84%
DSGX Yearly Profit, Operating, Gross MarginsDSGX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

8

2. Health

2.1 Basic Checks

DSGX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
There is no outstanding debt for DSGX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
DSGX Yearly Shares OutstandingDSGX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
DSGX Yearly Total Debt VS Total AssetsDSGX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

An Altman-Z score of 24.21 indicates that DSGX is not in any danger for bankruptcy at the moment.
DSGX has a Altman-Z score of 24.21. This is amongst the best in the industry. DSGX outperforms 95.65% of its industry peers.
DSGX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 24.21
ROIC/WACC0.72
WACC12.69%
DSGX Yearly LT Debt VS Equity VS FCFDSGX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.34 indicates that DSGX should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.34, DSGX is in line with its industry, outperforming 41.67% of the companies in the same industry.
A Quick Ratio of 1.34 indicates that DSGX should not have too much problems paying its short term obligations.
DSGX's Quick ratio of 1.34 is in line compared to the rest of the industry. DSGX outperforms 42.39% of its industry peers.
The current and quick ratio evaluation for DSGX is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.34
Quick Ratio 1.34
DSGX Yearly Current Assets VS Current LiabilitesDSGX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

8

3. Growth

3.1 Past

DSGX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.37%, which is quite impressive.
Measured over the past years, DSGX shows a very strong growth in Earnings Per Share. The EPS has been growing by 27.35% on average per year.
Looking at the last year, DSGX shows a quite strong growth in Revenue. The Revenue has grown by 14.90% in the last year.
DSGX shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.80% yearly.
EPS 1Y (TTM)21.37%
EPS 3Y30.71%
EPS 5Y27.35%
EPS Q2Q%35.48%
Revenue 1Y (TTM)14.9%
Revenue growth 3Y18%
Revenue growth 5Y15.8%
Sales Q2Q%16.62%

3.2 Future

Based on estimates for the next years, DSGX will show a very strong growth in Earnings Per Share. The EPS will grow by 24.26% on average per year.
DSGX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 11.40% yearly.
EPS Next Y27.15%
EPS Next 2Y23.44%
EPS Next 3Y27.6%
EPS Next 5Y24.26%
Revenue Next Year14.44%
Revenue Next 2Y12.92%
Revenue Next 3Y12.68%
Revenue Next 5Y11.4%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
DSGX Yearly Revenue VS EstimatesDSGX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B
DSGX Yearly EPS VS EstimatesDSGX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 71.73, DSGX can be considered very expensive at the moment.
DSGX's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of DSGX to the average of the S&P500 Index (29.19), we can say DSGX is valued expensively.
A Price/Forward Earnings ratio of 55.85 indicates a quite expensive valuation of DSGX.
DSGX's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 96.58. DSGX is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 71.73
Fwd PE 55.85
DSGX Price Earnings VS Forward Price EarningsDSGX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, DSGX is valued a bit cheaper than 71.01% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, DSGX is valued a bit cheaper than 64.86% of the companies in the same industry.
Industry RankSector Rank
P/FCF 47.79
EV/EBITDA 42
DSGX Per share dataDSGX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of DSGX may justify a higher PE ratio.
DSGX's earnings are expected to grow with 27.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.64
PEG (5Y)2.62
EPS Next 2Y23.44%
EPS Next 3Y27.6%

0

5. Dividend

5.1 Amount

No dividends for DSGX!.
Industry RankSector Rank
Dividend Yield N/A

DESCARTES SYSTEMS GRP/THE

NASDAQ:DSGX (2/12/2025, 8:07:12 PM)

After market: 114.05 0 (0%)

114.05

-4.64 (-3.91%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)12-03 2024-12-03/amc
Earnings (Next)03-05 2025-03-05/amc
Inst Owners87.2%
Inst Owner Change-32.11%
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap9.75B
Analysts77.78
Price Target77.45 (-32.09%)
Short Float %0.61%
Short Ratio2.33
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.35%
Min EPS beat(2)-0.16%
Max EPS beat(2)2.86%
EPS beat(4)3
Avg EPS beat(4)0.99%
Min EPS beat(4)-0.16%
Max EPS beat(4)2.86%
EPS beat(8)5
Avg EPS beat(8)0.6%
EPS beat(12)7
Avg EPS beat(12)0.83%
EPS beat(16)11
Avg EPS beat(16)4.61%
Revenue beat(2)2
Avg Revenue beat(2)1.55%
Min Revenue beat(2)1%
Max Revenue beat(2)2.1%
Revenue beat(4)3
Avg Revenue beat(4)0.98%
Min Revenue beat(4)-1.11%
Max Revenue beat(4)2.1%
Revenue beat(8)6
Avg Revenue beat(8)0.34%
Revenue beat(12)9
Avg Revenue beat(12)0.72%
Revenue beat(16)13
Avg Revenue beat(16)1.32%
PT rev (1m)-0.04%
PT rev (3m)-0.81%
EPS NQ rev (1m)-2.1%
EPS NQ rev (3m)-6.13%
EPS NY rev (1m)0.08%
EPS NY rev (3m)2%
Revenue NQ rev (1m)2.5%
Revenue NQ rev (3m)4.26%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.4%
Valuation
Industry RankSector Rank
PE 71.73
Fwd PE 55.85
P/S 15.43
P/FCF 47.79
P/OCF 46.57
P/B 7.19
P/tB 126.56
EV/EBITDA 42
EPS(TTM)1.59
EY1.39%
EPS(NY)2.04
Fwd EY1.79%
FCF(TTM)2.39
FCFY2.09%
OCF(TTM)2.45
OCFY2.15%
SpS7.39
BVpS15.87
TBVpS0.9
PEG (NY)2.64
PEG (5Y)2.62
Profitability
Industry RankSector Rank
ROA 8.51%
ROE 10.16%
ROCE 11.9%
ROIC 9.11%
ROICexc 10.46%
ROICexgc N/A
OM 26.37%
PM (TTM) 21.8%
GM 75.43%
FCFM 32.28%
ROA(3y)7.64%
ROA(5y)6.35%
ROE(3y)9.1%
ROE(5y)7.5%
ROIC(3y)8.3%
ROIC(5y)7.07%
ROICexc(3y)10.84%
ROICexc(5y)8.83%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.85%
ROCE(5y)9.24%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y19.94%
ROICexc growth 5Y13.19%
OM growth 3Y6.52%
OM growth 5Y8.82%
PM growth 3Y10.63%
PM growth 5Y12.21%
GM growth 3Y0.73%
GM growth 5Y0.84%
F-Score6
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 7.61%
Cap/Sales 0.85%
Interest Coverage 250
Cash Conversion 88.25%
Profit Quality 148.06%
Current Ratio 1.34
Quick Ratio 1.34
Altman-Z 24.21
F-Score6
WACC12.69%
ROIC/WACC0.72
Cap/Depr(3y)8.41%
Cap/Depr(5y)7.87%
Cap/Sales(3y)1.12%
Cap/Sales(5y)1.19%
Profit Quality(3y)185.06%
Profit Quality(5y)213.67%
High Growth Momentum
Growth
EPS 1Y (TTM)21.37%
EPS 3Y30.71%
EPS 5Y27.35%
EPS Q2Q%35.48%
EPS Next Y27.15%
EPS Next 2Y23.44%
EPS Next 3Y27.6%
EPS Next 5Y24.26%
Revenue 1Y (TTM)14.9%
Revenue growth 3Y18%
Revenue growth 5Y15.8%
Sales Q2Q%16.62%
Revenue Next Year14.44%
Revenue Next 2Y12.92%
Revenue Next 3Y12.68%
Revenue Next 5Y11.4%
EBIT growth 1Y17.47%
EBIT growth 3Y25.69%
EBIT growth 5Y26%
EBIT Next Year97.22%
EBIT Next 3Y37.65%
EBIT Next 5Y27.97%
FCF growth 1Y12.14%
FCF growth 3Y16.63%
FCF growth 5Y22.62%
OCF growth 1Y11.77%
OCF growth 3Y16.54%
OCF growth 5Y21.6%